Larotrectinib Response in NTRK3 Fusion-Driven Diffuse High-Grade Glioma

High-grade glioma (HGG) and glioblastoma are the most common adult malignant brain tumors. The standard treatment consists of surgical resection followed by radiochemotherapy with temozolomide. The prognosis and the therapeutic options of these malignant brain tumors however are limited. Here, we describe a case of a patient with HGG with a previously unknown NTRK3 fusion that showed an extraordinary response to treatment with larotrectinib. This case supports regular testing for NTRK fusion proteins.

Location
Deutsche Nationalbibliothek Frankfurt am Main
Extent
Online-Ressource
Language
Englisch

Bibliographic citation
Larotrectinib Response in NTRK3 Fusion-Driven Diffuse High-Grade Glioma ; volume:107 ; number:7-8 ; year:2022 ; pages:433-438 ; extent:5
Pharmacology ; 107, Heft 7-8 (2022), 433-438 (gesamt 5)

Creator
König, David
Hench, Jürgen
Frank, Stephan
Dima, Laura
Bratic Hench, Ivana
Läubli, Heinz

DOI
10.1159/000524399
URN
urn:nbn:de:101:1-2022071400312320802308
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
15.08.2025, 7:26 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Associated

  • König, David
  • Hench, Jürgen
  • Frank, Stephan
  • Dima, Laura
  • Bratic Hench, Ivana
  • Läubli, Heinz

Other Objects (12)